Geneos Therapeutics Secures $5 Million in Series A3 Financing
Proceeds to Fund Expansion of Phase 1b/2a Trial of Personalized Therapeutic Cancer Vaccine in Liver Cancer
Financing adds 3B Future Health Fund to Investor Syndicate and Dr. Roberto DePonti as Board Observer
PLYMOUTH MEETING, Pa., April 12, 2023 -- ... Biopharmaceuticals, Oncology, Venture Capital Geneos Therapeutics, personalized therapeutic cancer vaccines
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Liver | Pharmaceuticals | Urology & Nephrology | Vaccines | Venture Capital